Simvastatin, an HMG-CoA reductase inhibitor, induces the synthesis and secretion of apolipoprotein AI in HepG2 cells and primary hamster hepatocytes

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

Ulrich K. Laemmli · Nature · 1970 · 251K citations

Protein Assembly, Natural Sciences, Structural Proteins +8

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Anders Olsson, John J.V. McMurray, G Thorgeirsson et al. · The Lancet · 1994 · 8.5K citations

Cardiovascular Disease, Health Policy, Hyperlipidemia +8

Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol

Hanna E. Bloomfield, Sander J. Robins, Dorothea Collins et al. · New England Journal of Medicine · 1999 · 3.4K citations · Full text

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

SCANDINAVIANSIMVASTATINSURVIVAL · The Lancet · 1994 · 2.4K citations

Cardiovascular Disease, Health Policy, Hyperlipidemia +8

Comparative Dose Efficacy Study of Atorvastatin Versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in Patients With Hypercholesterolemia (The CURVES Study) fn1fn1This study was supported by Parke-Davis, Division of Warner Lambert Company, Morris Plains, New Jersey. Manuscript received August 20, 1997; revised manuscript received and accepted November 24, 1997.

Peter J.H. Jones, Stephanie D. Kafonek, Irene Laurora et al. · The American Journal of Cardiology · 1998 · 1.1K citations

Lipid Disorder, Curves Study, Cardiovascular Disease +9